The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
Public ClinicalTrials.gov record NCT00573157. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Study identification
- NCT ID
- NCT00573157
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- EMD Serono
- Industry
- Enrollment
- 6 participants
Conditions and interventions
Conditions
Interventions
- Atacicept Drug
- Mycophenolate mofetil Drug
- Placebo Drug
- Corticosteroids Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2007
- Primary completion
- Mar 31, 2009
- Completion
- Mar 31, 2009
- Last update posted
- Mar 22, 2016
2007 – 2009
United States locations
- U.S. sites
- 12
- U.S. states
- 6
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tulane University Hospital and Clinic Department of Internal Medicine | New Orleans | Louisiana | — | — |
| Northwest Louisiana Nephrology Research | Shreveport | Louisiana | 71101 | — |
| Wayne State University Lupus Database Departments of Internal Medicine and Obstetrics & Gynecology Division of Rheumatology Wayne State University School of Medicine | Detroit | Michigan | — | — |
| The Feinstein Institute for Medical Research | Manhasset | New York | 11030 | — |
| Seligman Center for Advanced Therapeutics | New York | New York | 10003 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27109 | — |
| Rheumatology Clinical Research Unit, Division of Rheumatology University Hospitals Case Medical Center | Beachwood | Ohio | 44122 | — |
| University of Cincinnati College of Medicine | Cincinnati | Ohio | 45267 | — |
| The Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| Southwest Rheumatology and Research Group, LLC | Middleburg Heights | Ohio | 44130 | — |
| 1711 St. Julian Place | Columbia | South Carolina | 29204 | — |
| ACME Research, LLC | Orangeburg | South Carolina | 29118 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00573157, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 22, 2016 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00573157 live on ClinicalTrials.gov.